4 results
Approved WMOPending
The objective of this phase-3 randomized study, with a double-blind treatment period of 8 weeksduration is to evaluate the efficacy and safety of the fixed dose combinations of TAK-491 pluschlorthalidone (40/12.5 mg and 40/25 mg) in subjects with…
Not approvedWill not start
To characterize the multiple-dose pharmacokinetics of varenicline in adolescent maleand female smoking subjects
Approved WMOCompleted
See protocol page 12The purpose of this clinical study is to evaluate the safety and efficacy of the Micra Transcatheter Pacing system and to assess long-term device performance.
Approved WMOCompleted
This study is aimed to determine the efficacy of varenicline in reducing EDS in PD patients.